Fritextsökning
Innehållstyper
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Faster sales but less profits for Probi
The probiotic company increases its turnover, and the net results are twice as large as last year.
-
Nya konkurrenter kommer
Satsningarna för att hitta innovativa affärsmodeller för läkemedelsbranschen ökar kraftigt. Men det är inte läkemedelsbolagen som satsar mest.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
-
Acadia drug awarded
Acadia Pharmaceutical has got an award for a new treatment against Parkinson's disease.
-
Här är hela listan med de svenska ERC-miljonerna
Totalt har 236 forskare fått pengar från det europeiska forskningsrådet ERC. Tolv av dem kommer att arbeta med sina projekt i Sverige.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Samarbetsdags för Big Pharma
Patientkontakt via sociala medier, mobilstödd övervakning av dosering eller datastödd läkemedelsutveckling. Framtidens big pharma-bolag måste vidga vyerna och l...
-
Ny och vassare mjukvara från CLC Bio
Danska CLC Bio har byggt ut sin mjukvaruplattform för genomisk analys med nytt stöd för både mikroarraybaserade och digitala genuttrycksmätningar samt extra sna...
-
820 miljoner till medicinsk forskning
359 projekt inom området för medicin får pengar från Vetenskapsrådet i år. I snitt kammar varje projekt hem 670 000 kronor i årets runda.
-
Prenatal testing breakthrough
For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.
-
EU says yes to Roche drug
EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.
-
Focusing on Medicon Valley
Copenhagen Capacity and Invest in Skåne are hosting a seminar to promote the geographical area known as Medicon Valley. Some of the 350 life science companies f...
-
Oslo Cancer Cluster
Cancer is, of course, the focus for this Oslo-based cluster, which is solely dedicated to cancer treatment and diagnostics. Oslo cancer cluster is also a part o...
-
Parnevik firm in Swiss osteoporosis deal
The golf legend Jesper Parnevik's drug delivery firm EffRx has signed a license agreement with Nycomed for a new drug against osteoporosis.
-
Lättkalibrerad serie enhandspipetter
Brand Transferpette S är en ny serie pipetter från Brandtech Scientific med fokus lagt speciellt på komfort och prestanda.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
Glucose facilitates the use of indigo
The Finnish researcher Anne Vuorema oat the MTT Agrifood Research Finland proves in her new doctoral dissertation that glucose can serve as a reducing agent of indigo.
-
Pengar och support på önskelistan
I senaste Scanbaltrapporten identifierar organisationen fem huvudområden för att förbättra förutsättningarna inom life scienceindustrin i länderna kringa Baltik...
-
A platform for dialogue
As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...
-
Retorik som kan betyda allt eller inget
Blir allt som nyligen sagts sanning har life science-Sverige precis överösts av goda nyheter.
-
Life science management for hire
Do you need help getting your biotech company off and running? Camoleon is a new type of consultant that offers help with business and innovation management and...